Company:  NEUBASE THERAPEUTICS, INC ... (NBSE)
Form Type:  8-K/A
Filing Date:  7/11/2019 
CIK:  0001173281 
Address:  700 TECHNOLOGY DRIVE 
City, State, Zip:  PITTSBURGH, Pennsylvania 15219 
Telephone:  (646) 450-1790 
Fiscal Year:  09/30 
Last Trade
Last Trade: 
$4.18  
Change: 
-0.01 (-0.24%)  
Trade Time: 
Jul 19  
Market Cap: 
$64.89M
Trade NBSE now with 

© 2019  
Description of Business
Ohr Pharmaceutical, Inc. ("we," "us," "our," "Ohr," or the "Company") is a pharmaceutical company which has been focused on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Recent Developments On January 2, 2019, the Company, Ohr Acquisition Corp., a Delaware corporation and a wholly-owned subsidiary of Ohr ("Merger Sub"), and NeuBase Therapeutics, Inc., a Delaware corporation ("NeuBase"), entered into an Agreement and Plan of Merger and Reorganization (the "Merger Agreement"), pursuant to which, among other things, subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into NeuBase, with NeuBase becoming a wholly-owned subsidiary of the Company and the surviving corporation of the merger (the "Merger").
Register and access this filing in:     
  FORM 8-K/A
    SECTION 5 CORPORATE GOVERNANCE
      Item 5.07 Submission of Matters to a Vote of Security Holders.
    SECTION 8 OTHER EVENTS
      Item 8.01 Other Events.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURE